TUBGCP3

TUBGCP3 (GCP3) is an essential structural subunit of the γ-tubulin small complex (γ-TuSC) and the γ-tubulin ring complex (γ-TuRC), where it directly binds γ-tubulin and is required for microtubule nucleation at centrosomes (PMID:8670895, PMID:9566969, PMID:11694571). Within the γ-TuRC, GCP3 serves as the direct docking site for the conserved nucleation activator MOZART1/MZT1 via its N-terminal region and acts as a bridging scaffold that connects NEDD1 to the complex lumen (PMID:24006493). Loss of GCP3 causes monopolar spindle formation, M-phase arrest, and impaired cell proliferation across organisms from yeast to zebrafish, establishing it as a critical mitotic regulator (PMID:31178691, PMID:33482282). The protein is functionally conserved from yeast (Spc98p) to humans, and its stoichiometry within the γ-TuSC—together with GCP2 and two γ-tubulin molecules—has been defined by native complex purification (PMID:9384578, PMID:23886939).

1. 1996 High

   The fundamental question of how γ-tubulin function is supported at the spindle pole body was answered by identifying Spc98p (GCP3 ortholog) as a direct physical partner of γ-tubulin, establishing the first known accessory subunit of a γ-tubulin complex.

   Evidence Dosage suppressor screen, yeast two-hybrid, co-immunoprecipitation, and synthetic lethality in S. cerevisiae

   PMID:8670895

   Open questions at the time

   • Mammalian ortholog not yet identified
   • Stoichiometry of the complex unknown
   • Mechanism by which the complex nucleates microtubules unresolved
2. 1997 High

   The composition and stoichiometry of the γ-tubulin complex were defined: Spc98p, Spc97p, and two or more Tub4p molecules form a discrete unit that docks to the SPB via the Spc110p N-terminal domain, resolving how the complex is tethered to the nucleation site.

   Evidence Native complex purification and co-immunoprecipitation with domain-mapping in yeast

   PMID:9384578

   Open questions at the time

   • Whether the same stoichiometry applies in metazoan cells unknown
   • The larger ring complex not yet discovered
3. 1998 High

   Identification of human GCP3 and demonstration that it is functionally required for centrosomal microtubule nucleation established evolutionary conservation and provided the first direct functional evidence for the protein in mammalian cells.

   Evidence Co-immunoprecipitation, sucrose gradient sedimentation, antibody inhibition of nucleation on isolated centrosomes and in microinjected cells

   PMID:9566967 PMID:9566969

   Open questions at the time

   • Structure of the human γ-tubulin complex unresolved
   • Whether GCP3 participates in a larger complex beyond the γ-TuSC unknown
4. 1998 High

   Spc98p was shown to contain an essential NLS directing nuclear import of the assembled complex and to undergo cell-cycle-dependent phosphorylation at the nuclear SPB face, linking GCP3 to cell-cycle regulation of nucleation.

   Evidence NLS mutagenesis, cell fractionation, phosphorylation analysis, and mps1 genetic epistasis in yeast

   PMID:9529377

   Open questions at the time

   • Whether phosphorylation directly regulates nucleation activity unclear
   • Kinase–substrate relationship with Mps1 not biochemically confirmed
5. 2001 High

   Mass spectrometry of the purified human γ-TuRC confirmed GCP3 as a core subunit of a larger ~25 nm ring complex (with GCP2–GCP6 and γ-tubulin) capable of nucleating microtubules in vitro, answering the question of whether a metazoan ring complex exists beyond the γ-TuSC.

   Evidence Native complex purification, mass spectrometry, EM, in vitro nucleation assay

   PMID:11694571

   Open questions at the time

   • High-resolution structure of the ring complex lacking
   • How GCP3 is arranged within the ring unknown
6. 2002 High

   Discovery that CG-NAP and kendrin anchor the γ-TuRC at the centrosome by binding GCP2/GCP3 identified the first centrosomal receptors for the complex, resolving the question of how the nucleation machinery is physically tethered.

   Evidence Yeast two-hybrid, co-immunoprecipitation, antibody inhibition of centrosomal nucleation

   PMID:12221128

   Open questions at the time

   • Relative contributions of CG-NAP vs. kendrin to GCP3-mediated tethering not dissected
   • Whether additional tethering mechanisms exist unknown
7. 2007 Medium

   CDK5RAP2 was identified as a γ-TuRC attachment factor at centrosomes whose perturbation delocalizes γ-tubulin without disrupting complex assembly, establishing a separation between complex formation and centrosomal recruitment.

   Evidence RNAi, overexpression, co-immunoprecipitation, immunofluorescence in human cells

   PMID:17959831

   Open questions at the time

   • GCP3 not directly manipulated in these experiments
   • Direct binding site on GCP3 not mapped
8. 2013 High

   MOZART1/MZT1 was shown to directly bind the N-terminal region of GCP3, identifying GCP3 as the specific docking subunit for this conserved nucleation activator and answering the question of how MZT1 is recruited to the γ-tubulin complex.

   Evidence Yeast two-hybrid, biophysical assays with recombinant proteins, conditional depletion in fission yeast

   PMID:24006493

   Open questions at the time

   • Structural basis of the MZT1–GCP3 interface not resolved at atomic level at this time
   • Whether MZT1 binding modulates GCP3 conformation unknown
9. 2013 High

   Cross-species complementation demonstrated that human GCP3 can fully replace fission yeast Alp6, proving structural and functional conservation and revealing that GCP2 and GCP3 have non-equivalent roles within the γ-TuSC.

   Evidence Genetic complementation, sucrose gradient sedimentation, chimeric protein analysis in fission yeast

   PMID:23886939

   Open questions at the time

   • Molecular determinants underlying GCP3's distinct role vs. GCP2 not identified
   • N-terminal domain swap experiments not performed for GCP3
10. 2019 High

    In vivo loss of Tubgcp3 in zebrafish established that GCP3 is essential for bipolar spindle formation and retinal progenitor cell proliferation, translating cell-biological knowledge to a vertebrate developmental context.

    Evidence CRISPR/Cas9 knockout in zebrafish with immunofluorescence, cell cycle, and apoptosis analysis

    PMID:31178691

    Open questions at the time

    • Whether partial loss of function produces milder or tissue-specific phenotypes unknown
    • No human disease association established
11. 2024 High

    Cryo-EM structures revealed that GCP3, in subcomplexes with MZT1, serves as a bridging scaffold connecting NEDD1 to the γ-TuRC lumen, providing the first high-resolution view of GCP3's architectural role and explaining how NEDD1 is recruited to the complex.

    Evidence Cryo-EM structure, AlphaFold modeling, pull-down mutagenesis (preprint)

    PMID:bio_10.1101_2024.11.05.622067

    Open questions at the time

    • Preprint; peer-reviewed validation pending
    • Whether NEDD1–GCP3 interaction is regulated by post-translational modifications unknown
    • Functional consequences of disrupting the GCP3–NEDD1 bridge on nucleation not tested

• Key unresolved questions include whether post-translational modifications of GCP3 directly regulate nucleation activity, whether GCP3 mutations cause human Mendelian disease, and how GCP3 contributes to nucleation at non-centrosomal MTOCs in differentiated tissues.
• No human genetic disease linked to TUBGCP3 mutations reported
• Regulation of GCP3 by phosphorylation or other modifications in mammalian cells unexplored
• Role at acentrosomal MTOCs (e.g. Golgi, nuclear envelope) not directly tested